Antibiotic resistance in Campylobacter and other diarrheal pathogens isolated from US military personnel deployed to Thailand in 2002-2004: a case-control study
- PMID: 28883983
- PMCID: PMC5530911
- DOI: 10.1186/s40794-017-0056-y
Antibiotic resistance in Campylobacter and other diarrheal pathogens isolated from US military personnel deployed to Thailand in 2002-2004: a case-control study
Abstract
Background: Campylobacter continues to be an important cause of diarrheal disease worldwide and a leading cause in Southeast Asia. Studies of US soldiers and marines deployed to Thailand for a 2 to 3 week field exercise provide a unique population in which to study traveler's diarrhea.
Methods: A case-control study of 217 deployed military personnel was conducted from 2002 through 2004. Of these, 155 subjects who presented to a field medical unit with acute diarrhea were enrolled as cases. These subjects referred an additional 62 diarrhea-free colleagues who served as controls. Frequencies of isolation of Campylobacter spp. and other enteric pathogens were compared in cases and controls, and antibiotic resistance of isolates was described.
Results: Of the 155 subjects with diarrhea, Campylobacter spp. was the most commonly identified pathogen, found in 54 (35%) of the subjects, followed by non-typhoidal Salmonella species found in 36 (23%) subjects. Of the 57 separate C. jejuni and C. coli isolates from these individuals, 51 (89%) were resistant to ciprofloxacin by the disc diffusion method. Nearly one-third of the Campylobacter species were resistant to ampicillin and trimethoprim-sulfamethoxazole. Resistance to azithromycin remained low at 2% (n = 1).
Conclusions: The significant morbidity and marked fluoroquinolone resistance associated with Campylobacter infections in Thailand are important considerations for clinicians providing counseling on appropriate antibacterial regimens for civilian and military travelers.
Keywords: Antibiotic resistance; Campylobacter; Cobra Gold; Military personnel; Thailand; Traveler’s diarrhea.
Conflict of interest statement
Ethics approval and consent to participate
The study protocols were approved by the Institutional Review Board of Walter Reed Army Institute of Research (WRAIR IRB) as human subject research in compliance with the Helsinki Declaration guidelines. Written informed consent was obtained from each potential subject prior to participation in the study.
Consent for publication
Not applicable. No individual data is presented. All results include aggregate data.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Enteric etiological surveillance in acute diarrhea stool of United States Military Personnel on deployment in Thailand, 2013-2017.Gut Pathog. 2020 Apr 9;12:17. doi: 10.1186/s13099-020-00356-7. eCollection 2020. Gut Pathog. 2020. PMID: 32308742 Free PMC article.
-
An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection.Am J Trop Med Hyg. 2002 Nov;67(5):533-8. doi: 10.4269/ajtmh.2002.67.533. Am J Trop Med Hyg. 2002. PMID: 12479558
-
PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003.Gut Pathog. 2010 Nov 10;2(1):15. doi: 10.1186/1757-4749-2-15. Gut Pathog. 2010. PMID: 21062505 Free PMC article.
-
Prevention and treatment of traveler's diarrhea.Am Fam Physician. 1999 Jul;60(1):119-24, 135-6. Am Fam Physician. 1999. PMID: 10414633 Review.
-
Etiology and epidemiology of travelers' diarrhea in Asia.Rev Infect Dis. 1986 May-Jun;8 Suppl 2:S136-41. doi: 10.1093/clinids/8.supplement_2.s136. Rev Infect Dis. 1986. PMID: 3523709 Review.
Cited by
-
First report of phenotypic and genotypic (blaOXA-61) beta-lactam resistance in Campylobacter jejuni from broilers in Indonesia.Vet World. 2023 Nov;16(11):2210-2216. doi: 10.14202/vetworld.2023.2210-2216. Epub 2023 Nov 2. Vet World. 2023. PMID: 38152271 Free PMC article.
-
Prosthetic hip infection due to Campylobacter jejuni.BMJ Case Rep. 2022 Mar 10;15(3):e248240. doi: 10.1136/bcr-2021-248240. BMJ Case Rep. 2022. PMID: 35272991 Free PMC article.
-
Understanding the etiology of diarrheal illness in Cambodia in a case-control study from 2020 to 2023.Gut Pathog. 2025 May 22;17(1):32. doi: 10.1186/s13099-025-00709-0. Gut Pathog. 2025. PMID: 40405224 Free PMC article.
-
Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta).PLoS One. 2023 Dec 13;18(12):e0294021. doi: 10.1371/journal.pone.0294021. eCollection 2023. PLoS One. 2023. PMID: 38091314 Free PMC article.
-
Acute Bacterial Gastroenteritis.Gastroenterol Clin North Am. 2021 Jun;50(2):283-304. doi: 10.1016/j.gtc.2021.02.002. Epub 2021 Apr 23. Gastroenterol Clin North Am. 2021. PMID: 34024442 Free PMC article. Review.
References
-
- Gascon J. Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion. 2006;73 Suppl 1:102–8. - PubMed
-
- Walz SE, Baqar S, Beecham HJ, Echeverria P, LeBron C, McCarthy M, et al. Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand. Am J Trop Med Hyg. 2001;65:652–656. doi: 10.4269/ajtmh.2001.65.652. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous